GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nuwellis Inc (NAS:NUWE) » Definitions » Float Percentage Of Total Shares Outstanding

Nuwellis (Nuwellis) Float Percentage Of Total Shares Outstanding : 99.98% (As of May. 24, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Nuwellis Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nuwellis's float shares is 18.05 Mil. Nuwellis's total shares outstanding is 18.05 Mil. Nuwellis's float percentage of total shares outstanding is 99.98%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nuwellis's Insider Ownership is 32.75%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nuwellis's Institutional Ownership is 0.08%.


Nuwellis Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Nuwellis's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=18.05/18.05
=99.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuwellis (Nuwellis) Business Description

Industry
Traded in Other Exchanges
Address
12988 Valley View Road, Eden Prairie, MN, USA, 55344
Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
Executives
David Mcdonald director 6 KEMPTON PLACE, #12, SARATOGA SPRINGS NY 12866
Archelle Georgiou Feldshon director 1420 SHORELINE DRIVE, WAYZATA MN 55391
Robert Benjamin Scott officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Kendrick Mccormick director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Gregory D Waller director 1717 W COLLINS AVENUE, ORANGE CA 92867
Jon W Salveson director 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Nestor Jr. Jaramillo officer: Chief Commercial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Lynn Larson Blake officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
George Montague officer: CFO and Treasurer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Neil P Ayotte officer: SVP, Secretary, GC & CCO 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Paul Wotta officer: Principal Accounting Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Claudia Drayton officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Thomas P. Lynch officer: Chief Legal/Compliance Officer 3344 N. TORREY PINES COURT, LA JOLLA CA 92037
Steven Frank Brandt director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Maria Rosa Costanzo director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344